MoneyWorks4Me

Sun Pharma gets USFDA’s nod for Oxymorphone Hydrochloride

30 Apr 2015 Evaluate

Sun Pharmaceutical Industries has received US Food and Drugs Administration’s (USFDA) approval for a painkiller tablet called ‘Oxymorphone Hydrochloride’. Including this medicine, the company has received total seven approvals from US FDA in last one year, these medicine are- Oxymorphone Hydrochloride, Fesoterodine Fumarate, Opcicon One-step, Clonazepam, Clonidine Hydrochloride, Hydrochlorothiazide and Furosemide.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma. Inds. Share Price

1899.00 -5.00 (-0.26%)
04-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.00
Dr. Reddys Labs. 1154.00
Cipla 1385.00
Lupin 2111.00
Zydus Lifesciences 1121.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: